These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17383015)

  • 21. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
    Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
    Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
    Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):301-6. PubMed ID: 18588590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cholinesterase inhibitors and depression in the elderly].
    Amara G; Saada W; Ben Nasr S; Ben Hadj Ali B
    Encephale; 2010 Feb; 36(1):77-81. PubMed ID: 20159200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
    Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants.
    Berlim MT; Pargendler J; Brenner J; Fleck MP
    Psychiatry Res; 2007 Dec; 153(3):253-9. PubMed ID: 17675247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.
    Todder D; Caliskan S; Baune BT
    World J Biol Psychiatry; 2009; 10(4):276-84. PubMed ID: 19921969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical comorbidity affects antidepressant treatment response in patients with melancholic depression.
    Pohle K; Domschke K; Roehrs T; Arolt V; Baune BT
    Psychother Psychosom; 2009; 78(6):359-63. PubMed ID: 19738401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
    Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):197-202. PubMed ID: 18412843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY
    Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study.
    Soudry A; Dufouil C; Ritchie K; Dartigues JF; Tzourio C; Alpérovitch A
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):324-30. PubMed ID: 17907265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder.
    Okuda A; Suzuki T; Kishi T; Yamanouchi Y; Umeda K; Haitoh H; Hashimoto S; Ozaki N; Iwata N
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):268-73. PubMed ID: 20602727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid hormones affect recovery from depression during antidepressant treatment.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):305-13. PubMed ID: 19566761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.